| |
| |
|
| Insider
Information: |
Gorlin Steve |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
2,272,172 |
|
|
Indirect Shares
|
6,060,392 |
|
|
| Direct
Value |
$889,811 |
|
|
|
Indirect Value
|
$6,360,756 |
|
|
| Total
Shares |
8,332,564 |
|
|
| Total
Value |
$7,250,567 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
2
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
-2.0
|
| Percentage
Gain/Loss : |
 73.9%
|
 -157.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Director, 10% Owner |
|
0 |
2005-06-08 |
2,657,317 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2013-05-16 |
11,500 |
2013-05-16 |
886,645 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
Director |
|
0 |
2008-02-12 |
2,271,330 |
Premium* |
|
|
Medovex Corp. |
MDVX |
Director within last 9... |
2017-10-30 |
1,640,704 |
2014-12-18 |
125,000 |
Premium* |
|
|
Ontrak, Inc |
OTRK |
Director |
2015-10-16 |
450,000 |
2018-06-15 |
100,000 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
2019-06-06 |
92,592 |
2018-11-29 |
0 |
Premium* |
|
|
PolarityTE, Inc |
PTE |
Director |
2019-08-06 |
31,018 |
|
0 |
Premium* |
|
|
Biovie Inc. |
BIVI |
Director |
2023-12-01 |
46,358 |
2020-10-15 |
20,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-29 |
4 |
S |
$3.89 |
$8,175 |
I/I |
(2,100) |
403,900 |
0 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-11-03 |
4 |
B |
$7.95 |
$19,319 |
D/D |
2,430 |
45,100 |
2.39 |
% |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-18 |
4 |
B |
$0.70 |
$1,750 |
D/D |
2,500 |
29,500 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-21 |
4 |
B |
$0.70 |
$1,750 |
D/D |
2,500 |
32,000 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-24 |
4 |
B |
$0.69 |
$1,725 |
D/D |
2,500 |
40,700 |
2.31 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-30 |
4 |
B |
$7.97 |
$20,483 |
D/D |
2,570 |
42,670 |
2.39 |
% |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-30 |
4 |
S |
$3.88 |
$10,564 |
I/I |
(2,724) |
401,176 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-22 |
4 |
B |
$0.70 |
$2,100 |
D/D |
3,000 |
35,000 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-23 |
4 |
B |
$0.70 |
$2,240 |
D/D |
3,200 |
38,200 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-17 |
4 |
B |
$0.59 |
$2,040 |
D/D |
3,416 |
26,000 |
2.31 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-25 |
4 |
S |
$3.97 |
$14,294 |
I/I |
(3,600) |
406,000 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-29 |
4 |
B |
$0.75 |
$3,000 |
D/D |
4,000 |
47,200 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2010-03-30 |
4 |
B |
$1.55 |
$6,240 |
D/D |
4,000 |
78,800 |
2.39 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-07 |
4 |
B |
$9.42 |
$44,444 |
D/D |
4,718 |
19,718 |
2.39 |
% |
|
| OTRK |
Ontrak, Inc |
Director |
• • – |
2018-06-15 |
4 |
B |
$8.57 |
$40,966 |
I/I |
4,765 |
100,000 |
2.1 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2010-04-01 |
4 |
B |
$1.45 |
$7,515 |
D/D |
5,000 |
83,800 |
2.39 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2013-05-09 |
4 |
A |
$6.60 |
$33,000 |
D/D |
5,000 |
16,500 |
0 |
- |
|
| MDVX |
Medovex Corp. |
|
– • – |
2017-06-14 |
4 |
B |
$0.97 |
$4,850 |
D/D |
5,000 |
1,375,020 |
0.01 |
- |
|
| MDVX |
Medovex Corp. |
|
– • – |
2017-06-28 |
4 |
B |
$0.87 |
$4,370 |
D/D |
5,000 |
1,380,020 |
0.01 |
- |
|
| PTE |
PolarityTE, Inc |
Director |
– • – |
2017-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
23,333 |
0 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-21 |
4 |
B |
$9.19 |
$45,950 |
D/D |
5,000 |
40,100 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-15 |
4 |
B |
$10.18 |
$51,967 |
I/I |
5,100 |
20,100 |
2.1 |
% |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-21 |
4 |
S |
$3.90 |
$21,672 |
I/I |
(5,557) |
418,449 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-30 |
4 |
B |
$0.75 |
$4,575 |
D/D |
6,100 |
53,300 |
2.31 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-09-14 |
4 |
B |
$0.60 |
$4,500 |
D/D |
7,500 |
9,184 |
2.31 |
- |
|
117 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
